Marina Konopleva

Albert Einstein College of Medicine — United States

Medicine · Health Sciences

130h-index69.5kcitations2.1kworks5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(1027), Chronic Myeloid Leukemia Treatments(510), Acute Lymphoblastic Leukemia research(425), Chronic Lymphocytic Leukemia Research(317), CAR-T cell therapy research(236)

Publications2.1k total

Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Leukemia & lymphoma/Leukemia and lymphoma·2026
<i>TP53</i> loss traps AML in XPO7-NPAT nuclear transport fraud
Blood·2026Open Access
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level
Haematologica·2026Open Access
Hematopoietic effects of tagraxofusp in treatment‐naive patients with blastic plasmacytoid dendritic cell neoplasm
Cancer·2026Open Access
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Leukemia & lymphoma/Leukemia and lymphoma·2025Open Access
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
Leukemia·2025Open Access
Table S2. Ingenuity Pathway Analysis of LILRB3 antibody treated U937 cells from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025Open Access
Supplementary Figures from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025Open Access
Table S1. LILRB1-4 surface expression in AML patient samples from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025Open Access
Supplementary Methods from Sex-Biased &lt;i&gt;ZRSR2&lt;/i&gt; Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
2025Open Access
Supplementary Tables from Sex-Biased &lt;i&gt;ZRSR2&lt;/i&gt; Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
2025Open Access
Supplementary Figures S1-S8 from Sex-Biased &lt;i&gt;ZRSR2&lt;/i&gt; Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
2025Open Access
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025Open Access
Supplementary Data from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025Open Access
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Journal of Hematology & Oncology·2025· 1 citedOpen Access
Supplementary Figures from Single-Cell Profiling of CD8&lt;sup&gt;+&lt;/sup&gt; T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
2025Open Access
Clinical Trial Protocol S1 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies
2025Open Access
Supplementary Table S1 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies
2025Open Access
Supplementary Table S2 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies
2025Open Access
Table S1 from A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML
2025Open Access
page 1 of 105Next →

Frequent Co-authors

Hagop M. Kantarjian(30), Michael Andreeff(22), Farhad Ravandi(17), Courtney D. DiNardo(15), Jörge E. Cortes(15), Elias Jabbour(15), Tapan M. Kadia(12), Gautam Borthakur(12), Guillermo Garcia‐Manero(12), Steven M. Kornblau(11), Naval Daver(11), Nitin Jain(9), Zeev Estrov(8), Naveen Pemmaraju(8), Keyur P. Patel(7), Sherry Pierce(7), Susan O’Brien(7), Anthony Letai(6), Andrew H. Wei(5), Ismael Samudio(5)